Investor's Business Daily on MSN

The gene-editing news that sent beleaguered Intellia Therapeutics stock up

Intellia Therapeutics stock surged Tuesday after the FDA aid it would allow the company to restart a gene-editing study.
News Medical on MSN

First topical CRISPR gene therapy corrects disease-causing mutations in human skin

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
BioPharma Dive

FDA lifts hold on an Intellia CRISPR drug trial

Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...
Morning Overview on MSN

Gene editing breakthrough could kill off daily cholesterol pills

For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...
The Daily Pennsylvanian

Four Penn Medicine studies to be honored with national clinical research award

From projects examining healthcare initiative impacts to groundbreaking medical developments, the forum — which annually ...
Earth.com

Caffeine could give scientists precise control over gene editing

Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...
Iowa Public Radio

CRISPR gene-editing works to reduce high cholesterol in a new study

A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday. The study, which ...
OPB

CRISPR gene-editing works to reduce high cholesterol in a new study

TEK IMAGE/Science Photo Library / Getty Images/Science Photo Libra A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, ...